Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,933,850
  • Shares Outstanding, K 97,700
  • Annual Sales, $ 13,979 M
  • Annual Income, $ 1,556 M
  • 60-Month Beta 1.04
  • Price/Sales 2.06
  • Price/Cash Flow 8.36
  • Price/Book 2.81
Trade LH with:

Options Overview

Details
  • Implied Volatility 22.43%
  • Historical Volatility 16.66%
  • IV Percentile 5%
  • IV Rank 4.68%
  • IV High 39.12% on 01/29/21
  • IV Low 21.61% on 05/28/21
  • Put/Call Vol Ratio 0.84
  • Today's Volume 261
  • Volume Avg (30-Day) 772
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 20,920
  • Open Int (30-Day) 20,069

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 4.29
  • Number of Estimates 7
  • High Estimate 4.58
  • Low Estimate 3.86
  • Prior Year 8.41
  • Growth Rate Est. (year over year) -48.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
271.46 +10.11%
on 07/19/21
304.73 -1.91%
on 08/04/21
+20.96 (+7.54%)
since 07/02/21
3-Month
256.81 +16.39%
on 06/17/21
304.73 -1.91%
on 08/04/21
+22.70 (+8.22%)
since 05/05/21
52-Week
170.05 +75.78%
on 08/27/20
304.73 -1.91%
on 08/04/21
+105.39 (+54.46%)
since 08/05/20

Most Recent Stories

More News
National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease

/PRNewswire/ -- New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines...

LH : 298.91 (-0.39%)
4 Medical Device Stocks Set to Beat This Earnings Season

Rebound in base sales makes us optimistic about HSIC, XRAY, GMED and ABC's results this time around.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
TMO : 542.35 (+0.64%)
ABC : 121.89 (-2.92%)
XRAY : 59.75 (-7.08%)
HSIC : 76.73 (-0.74%)
GMED : 79.90 (-0.91%)
3 Must-Own Healthcare Stocks for Your Portfolio

Healthcare stocks have had a steady run so far this year, with the industry’s growth prospects—based on ongoing digitization to revolutionize and increase demand—motivating investors. The industry’s...

MTD : 1,527.56 (+0.81%)
LH : 298.91 (-0.39%)
BRKR : 81.32 (-0.40%)
OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down

OPKO Health's (OPK) second-quarter results benefit from strength in both its reportable segments.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
WST : 425.66 (-0.58%)
OPK : 3.76 (+3.87%)
Merit Medical's (MMSI) Q2 Earnings Top Estimates, '21 View Up

Merit Medical (MMSI), in the second quarter, benefits from revenue growth across both its segments as well as across all the product categories within its Cardiovascular unit.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
MMSI : 66.99 (+1.50%)
WST : 425.66 (-0.58%)
Integer Holdings (ITGR) Beats on Q2 Earnings, Ups 2021 View

Integer Holdings' (ITGR) second-quarter results reflect robust segmental performances along with strength in majority of the product lines.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
WST : 425.66 (-0.58%)
ITGR : 93.54 (+0.31%)
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline

Faster-than-expected vaccination uptake leads to a reduction in demand for COVID-19 testing for QIAGEN (QGEN) in Q2.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
QGEN : 52.76 (+0.08%)
WST : 425.66 (-0.58%)
Teleflex (TFX) Q2 Earnings Surpass Estimates, Margins Up

Teleflex (TFX) reports better-than-expected revenues with strong segmental and geographical performance driving the top line in second-quarter 2021.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
TFX : 377.84 (+1.19%)
WST : 425.66 (-0.58%)
Omnicell (OMCL) Q2 Earnings Top Estimates, 2021 EPS View Up

Omnicell (OMCL) reports better-than-expected revenues on strong segmental performance driving the top line in second-quarter 2021.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
OMCL : 153.01 (+2.56%)
WST : 425.66 (-0.58%)
Bio-Rad (BIO) Q2 Earnings Top Estimates, 2021 View Raised

Strength in Life Science and Clinical Diagnostics segments during the second quarter drove Bio-Rad (BIO) revenues.

BSX : 44.65 (+0.88%)
LH : 298.91 (-0.39%)
BIO : 763.66 (+0.20%)
WST : 425.66 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class...

See More

Key Turning Points

3rd Resistance Point 311.74
2nd Resistance Point 307.61
1st Resistance Point 303.26
Last Price 298.91
1st Support Level 294.78
2nd Support Level 290.65
3rd Support Level 286.30

See More

52-Week High 304.73
Last Price 298.91
Fibonacci 61.8% 253.29
Fibonacci 50% 237.39
Fibonacci 38.2% 221.50
52-Week Low 170.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar